Literature DB >> 8806526

Functional consequences of natural sequence variation in the activation domain of HIV-1 Rev.

J Hua1, J J Caffrey, B R Cullen.   

Abstract

Initial infection with an attenuated form of human immunodeficiency virus type 1 (HIV-1) may give rise to some of the rare asymptomatic infections that have been observed. Recently, data have been presented suggesting that a persistent mutation in the essential activation domain of the HIV-1 Rev regulatory protein might have contributed to the maintenance of the asymptomatic state in one individual. Here, we have used a range of assays for in vivo Rev function to examine whether natural sequence variation in the normally highly conserved Rev activation domain can indeed affect Rev function. Analysis of five distinct natural sequence variants of the Rev domain demonstrated that each produced a two- to fourfold drop in Rev function when compared to the consensus activation domain sequence A sixth sequence, reported for the MN isolate of HIV-1, proved entirely inactive. However, resequencing of this region of the MN genome revealed that this isolate actually encodes a consensus Rev activation domain. Overall, these data reveal that even natural sequence variation in the essential Rev activation domain can result in significantly reduced Rev function and suggest that isolates containing such sequence variation are likely to replicate less effectively.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8806526     DOI: 10.1006/viro.1996.0439

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  10 in total

1.  Biological characterization of Rev variation in equine infectious anemia virus.

Authors:  M Belshan; M E Harris; A E Shoemaker; T J Hope; S Carpenter
Journal:  J Virol       Date:  1998-05       Impact factor: 5.103

Review 2.  A structurally plastic ribonucleoprotein complex mediates post-transcriptional gene regulation in HIV-1.

Authors:  Jason D Fernandes; David S Booth; Alan D Frankel
Journal:  Wiley Interdiscip Rev RNA       Date:  2016-03-01       Impact factor: 9.957

3.  Limited nucleotide changes in the Rev response element (RRE) during HIV-1 infection alter overall Rev-RRE activity and Rev multimerization.

Authors:  Emily A Sloan; Mary F Kearney; Laurie R Gray; Kathryn Anastos; Eric S Daar; Joseph Margolick; Frank Maldarelli; Marie-Louise Hammarskjold; David Rekosh
Journal:  J Virol       Date:  2013-08-07       Impact factor: 5.103

4.  Sequence and Functional Variation in the HIV-1 Rev Regulatory Axis.

Authors:  Patrick E H Jackson; Godfrey Dzhivhuho; David Rekosh; Marie-Louise Hammarskjold
Journal:  Curr HIV Res       Date:  2020       Impact factor: 1.581

5.  Protein structure and oligomerization are important for the formation of export-competent HIV-1 Rev-RRE complexes.

Authors:  Stephen P Edgcomb; Angelique Aschrafi; Elizabeth Kompfner; James R Williamson; Larry Gerace; Mirko Hennig
Journal:  Protein Sci       Date:  2008-01-24       Impact factor: 6.725

Review 6.  Rev variation during persistent lentivirus infection.

Authors:  Susan Carpenter; Wei-Chen Chen; Karin S Dorman
Journal:  Viruses       Date:  2011-01-11       Impact factor: 5.818

7.  The HIV-1 Rev response element (RRE) adopts alternative conformations that promote different rates of virus replication.

Authors:  Chringma Sherpa; Jason W Rausch; Stuart F J Le Grice; Marie-Louise Hammarskjold; David Rekosh
Journal:  Nucleic Acids Res       Date:  2015-04-08       Impact factor: 16.971

8.  A novel retroviral vector system to analyze expression from mRNA with retained introns using fluorescent proteins and flow cytometry.

Authors:  Patrick E H Jackson; Jing Huang; Monika Sharma; Sara K Rasmussen; Marie-Louise Hammarskjold; David Rekosh
Journal:  Sci Rep       Date:  2019-04-23       Impact factor: 4.379

9.  Pathogenicity and immunogenicity of attenuated, nef-deleted HIV-1 strains in vivo.

Authors:  Paul R Gorry; Dale A McPhee; Erin Verity; Wayne B Dyer; Steven L Wesselingh; Jennifer Learmont; John S Sullivan; Michael Roche; John J Zaunders; Dana Gabuzda; Suzanne M Crowe; John Mills; Sharon R Lewin; Bruce J Brew; Anthony L Cunningham; Melissa J Churchill
Journal:  Retrovirology       Date:  2007-09-23       Impact factor: 4.602

10.  Persistence of attenuated HIV-1 rev alleles in an epidemiologically linked cohort of long-term survivors infected with nef-deleted virus.

Authors:  Melissa J Churchill; Lisa Chiavaroli; Steven L Wesselingh; Paul R Gorry
Journal:  Retrovirology       Date:  2007-07-01       Impact factor: 4.602

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.